BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribeiro dos Santos JB, Ribeiro da Silva MR. Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rissardo JP, Caprara ALF. Gepants for Acute and Preventive Migraine Treatment: A Narrative Review. Brain Sci 2022;12. [PMID: 36552072 DOI: 10.3390/brainsci12121612] [Reference Citation Analysis]
2 Scuteri D, Tarsitano A, Tonin P, Bagetta G, Corasaniti MT. Focus on zavegepant: the first intranasal third-generation gepant. Pain Manag 2022. [PMID: 36189708 DOI: 10.2217/pmt-2022-0054] [Reference Citation Analysis]
3 Gibler RC, Knestrick KE, Reidy BL, Lax DN, Powers SW. Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? PHMT 2022;Volume 13:309-323. [DOI: 10.2147/phmt.s334744] [Reference Citation Analysis]